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Abstract
Despite advances in oncology care, infections from both community and healthcare settings 
remain a major cause of hospitalization and death among patients with cancer receiving 
chemotherapy. Neutropenia (low white blood cell count) is a common and potentially dangerous 
side effect in patients receiving chemotherapy treatments and may lead to higher risk of infection. 
Preventing infection during treatment can result in significant decreases in morbidity and mortality 
for patients with cancer. As part of the Centers for Disease Control and Prevention’s (CDC’s) 
Preventing Infections in Cancer Patients public health campaign, a public-private partnership was 
formed between the CDC Foundation and Amgen, Inc. The CDC’s Division of Cancer Prevention 
and Control developed and launched an interactive website, www.PreventCancerInfections.org, 
designed for patients with cancer undergoing chemotherapy. The site encourages patients to 
complete a risk assessment for developing neutropenia during their treatment. After completing 
the assessment, patients receive information about how to lower the risk for infection and keep 
themselves healthy while receiving chemotherapy.
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Cancer remains the second most common cause of death in the United States, accounting for 
about one of every four deaths (American Cancer Society, 2014). With improvements in 
survivorship and the growth and aging of the U.S. population, the total number of people 
living with cancer will continue to increase (Warren, Mariotto, Meekins, Topor, & Brown, 
2008). In addition, an estimated 60,000 patients with cancer are hospitalized each year in the 
United States for chemotherapy-induced neutropenia and, among those hospitalized, about 
4,100 will die from this complication (Caggiano, Weiss, Rickert, & Linde-Zwirble, 2005). 
Neutropenia and subsequent infectious complications are among the most serious treatment-
related toxicities of cancer treatment and result in preventable morbidity and mortality 
(Herbst et al., 2009; Lyman et al., 2010). Infections among immunosuppressed patients with 
cancer are life-threatening, with a mortality rate associated with febrile neutropenia of 2%–
21%, depending on the cancer type, type of chemotherapy, and other factors (Herbst et al., 
2009; Lyman et al., 2010; Smith et al., 2006). Infections can be difficult to identify in this 
vulnerable population given a lack of clinical signs and symptoms from neutropenia and a 
decreased febrile response (Lyman et al., 2010). As a result of this difficulty, a patient’s 
ability to recognize of the signs and symptoms of an infection is critical. Lowering the risk 
for developing infections is an important strategy to decrease poor outcomes (Herbst et al., 
2009), and education programs for this population may help them reduce their risk. Because 
patients with cancer increasingly obtain health education from the Internet to find relevant 
information, and one in three Americans turn to the Internet to diagnose a medical condition, 
an online program may be an effective way to provide patients with information to prevent 
infections (Chou, Liu, Post, & Hesse, 2011; Fox & Duggan, 2013; Suggs & McIntyre, 
2009).
To address these issues, a public-private partnership was formed between the Centers for 
Disease Control and Prevention (CDC) Foundation and Amgen, Inc. to help create the 
CDC’s Preventing Infections in Cancer Patients public health campaign. As part of this 
partnership, the CDC’s Division of Cancer Prevention and Control developed and launched 
an interactive website, 3 Steps Toward Preventing Infections During Cancer Treatment 
(www.preventcancerinfections.org). ICF International, a public health research and 
consulting firm, assisted with the development, launch, maintenance, and initial evaluation 
of the website. The site allows patients with cancer receiving chemotherapy to assess their 
risk for developing neutropenia during their treatment and provides them and their 
caregivers with information about how to recognize the signs and symptoms of an infection, 
what to do if these signs and symptoms occur, and steps they can take to prevent infections.
Methods
Development of the website occurred in five phases: (a) formative research; (b) website 
design and development of an external advisory board (EAB); (c) concept validation; (d) 
website development, testing, and launch; and (e) maintenance and initial evaluation 
activities.
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Phase 1: Formative Research
As a first step, an environmental scan was conducted consisting of three components: a 
review of published literature; a review of gray literature (unpublished literature from 
relevant Internet sources); and interviews with healthcare providers, researchers, patient 
advocates, and developers of other online patient education tools. The purpose of the 
environmental scan was to identify risk factors for developing neutropenia among patients 
with cancer, effective infection control practices to be implemented by patients with cancer, 
current practices of healthcare providers on infection control and patient education, and 
barriers and facilitators to healthcare providers’ use of an online education program for 
infection control with their patients. The environmental scan also identified previously 
developed online education programs for patients with cancer and potential challenges in the 
development of the programs.
Findings from the environmental scan informed the development of a logic model 
(www.preventcancerinfections.org/sites/default/files/LogicModel-FINAL.pdf) that guided 
the development and implementation of the website. The logic model was based on the 
understanding of information that patients and caregivers need, including awareness and 
knowledge about neutropenia and subsequent risk of infection, knowledge and skills about 
how to prevent infections, and knowledge and skills about how to quickly recognize and 
control infections when they do occur.
Phase 2: Website Design and Development of an External Advisory Board
Following the formative research, activities focused on website design and functionality and 
the creation of a risk assessment algorithm for the website. The environmental scan revealed 
certain factors (e.g., age, cancer type, chemotherapy regimen, the Eastern Cooperative 
Oncology Group performance status). The risk factors were used to develop an algorithm 
estimating a patient’s risk for developing neutropenia while receiving chemotherapy. The 
algorithm determines risk by assigning scores to responses to questions related to 
demographic and clinical characteristics (see Figure 1). Based on the answers, respondents 
are placed in either a low-risk or high-risk category and, according to this classification, 
provided with evidence-based information to reduce their risk for developing infections 
during chemotherapy treatment. The messages help patients and caregivers recognize the 
signs and symptoms of an infection and what to do if they develop any of these signs and 
symptoms.
In addition, the CDC assembled an EAB representing the fields of oncology and infection 
control, nursing, and patient advocacy. The role of the EAB was to provide input during the 
development of the website and to help with its dissemination into the patient and provider 
community. From October 2011 to January 2012, 11 EAB members (selected by the CDC 
based on expertise) contributed 2–3 hours per month completing assigned tasks and received 
no monetary compensation for their contributions to the project. Two EAB members still 
serve in an advisory capacity when needed.
During this phase, the EAB reviewed findings from the environmental scan and provided 
input into the development of the algorithm for assessing a patient’s risk for developing 
Dunbar et al. Page 3













neutropenia. During later phases of the project, EAB members reviewed focus group 
findings, evidence-based content for the website, branding concepts, a pilot testing plan, and 
dissemination strategies. Members of the EAB also assisted in other specific tasks. For 
example, the CDC conducted a site visit to one of the member’s outpatient clinics to better 
understand potential obstacles and facilitators in incorporating a web-based educational tool 
into a practice. In addition, several EAB members contacted representatives from their 
respective professional organizations to increase awareness, dissemination, and use of the 
website.
Phase 3: Concept Validation
A webinar was conducted with five researchers and health-care providers (including urban 
and rural oncology nurses, an oncologist, and an infectious disease physician) to further 
inform development of the website. Webinar participants were selected based on their 
experience working with patients with cancer or their expertise in infection control. The 
main objectives of the webinar were to confirm the findings of the environmental scan (i.e., 
the risk factors for developing neutropenia among patients with cancer), reach a consensus 
on questions for the website’s algorithm, review the website’s draft content, and obtain input 
on the delivery, use, and limitations of the website.
After the webinar was completed, 11 focus groups were conducted with a total of 64 cancer 
survivors, caregivers, and healthcare providers to better understand the perspectives of these 
audiences on preventing infections during cancer treatment and an online patient education 
tool (see Table 1). The focus groups were an important component of the concept validation 
phase in that they allowed direct interaction and conversation with the audiences for whom 
the website is intended.
Recruitment for all groups was conducted through local cancer centers, support groups, 
professional medical associations, and patient advocacy organizations. Content from the 
focus groups was transcribed and reviewed to conduct a content analysis of themes across 
all 11 focus groups that informed development of the website. As an example, to increase 
user acceptance, three preliminary website designs were evaluated by the patient, caregiver, 
and healthcare provider focus groups. Participants were asked to provide feedback on colors, 
images, graphic elements, structure, and content. One design was selected most frequently 
across all focus group participants and was ultimately chosen, with participants’ suggested 
revisions incorporated.
Phase 4: Website Development, Testing, and Launch
A web developer and database programmer used HTML and Microsoft.NET™ technologies 
to create the site. Many of the development tasks centered on integrating website design 
specifications, algorithm logic, and tailored infection control and prevention messages. The 
environmental scan revealed that the Internet has become a leading source for health 
information. However, to reach targeted audiences and ensure adoption of recommended 
practices and behaviors, information must be appealing, easy to understand, and educational 
(Bensley et al., 2004). During the development phase, the team was mindful of maintaining 
readability of the materials using plain language tactics to ensure a user-friendly website, 
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such as incorporating bullet lists and short paragraphs and sentences (Plain Language.gov, 
2011). The project team aimed to keep the website content to a sixth grade reading level; 
however, the necessary use of medical terminology increased the content to a seventh grade 
level. As a result, a glossary was added to provide users with definitions of this terminology 
in lay terms.
A development approach was employed that enables future modifications with minimal 
effort, therefore providing maximum flexibility for updates. The development approach also 
included the use of the software development life cycle method to guide the process and 
ensure the website met industry standards (Conger, 1993). Once a preliminary version of the 
website was complete, pilot testing was conducted with 24 respondents (physicians, nurses, 
caregivers, and patients) who had previously participated in the focus groups. Data were 
collected through a short, web-based survey. Information gathered from pilot testing, 
including quantitative satisfaction results and qualitative comments, were summarized and 
minor edits were made to clarify glossary terminology and risk assessment completion 
instructions.
Following these website revisions, promotional activities began by targeting key partner 
groups such as patient advocacy organizations, federal agencies, state and national 
organizations, as well as oncology, nursing, and infectious disease associations and 
societies. To garner support for the website and inspire key groups to promote and embed 
the website into their organizations’ existing websites, social media channels, and email 
blasts/communications to their memberships, the CDC conducted three teleconferences with 
these various partner organizations the week before the website was launched. The partners 
received a variety of resources, including the embargoed press release, fact sheets, posters, 
key messages, web buttons, tweets, e-cards, and an educational video explaining how to use 
the website and its benefits. Many partners posted this information on their organizations’ 
websites, sent out a separate email to their membership, and/or posted one of the web badges 
(directly linking the user to www.preventcancerinfections.org) on their own organization’s 
site. Partner efforts helped to drive traffic to the website and added to its exposure.
Using multiple marketing and dissemination channels to reach a diverse target audience was 
critical to the launch of the website on October 25, 2011. In addition to partners, the 
development group targeted traditional print and Internet-based media to ensure appropriate 
saturation for maximum audience exposure. Online and print coverage alone reached more 
than 12 million readers and helped drive the public to the site. In addition, a satellite media 
tour was conducted that had the potential to reach 2.9 million people. The developers also 
used social media outlets, including Facebook and Twitter, which garnered 357 total tweets, 
reaching more than 885,000 people. By using this multifaceted approach, the launch of 
resources alone reached more than 168 million impressions and more than 273 million 
impressions as of May 2013.
Phase 5: Maintenance and Initial Evaluation Activities
A maintenance phase has been in place since the launch. The goal is to track and document 
user feedback, monitor risk assessment questionnaire data, and track site usage through web 
analytics. Although users do not receive responses to their comments, the feedback feature 
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provides a mechanism for capturing accessibility, content, and/or general user concerns. In 
addition, data gathered from completed risk assessment questionnaires provide a snapshot of 
the demographic and clinical characteristics of website users. Web analytics data (e.g., site 
usage, sources of site traffic, average time on site, most frequently accessed content) also are 
analyzed and reported weekly (see Table 2).
Initial evaluation activities also were conducted during this phase to expand the 
understanding of how the website is used and incorporated into outpatient clinical settings. 
Site visits to two outpatient cancer treatment facilities were conducted and included in-depth 
interviews with staff and patients. Both facilities were identified and selected based on their 
staff’s involvement in the EAB and their use of the website within their facilities. Findings 
from these visits provided a concrete understanding of how the website and its collateral 
materials are used in the outpatient clinical setting (see Figure 2). Summary reports were 
developed, providing key information regarding the availability of process (e.g., the various 
ways the website is used by providers and patients) and outcome data (e.g., infection rates) 
that may help to inform the design of a more rigorous evaluation of the website.
As a final evaluation activity, interviews were conducted to gather input and lessons learned 
from two websites with similar content, purpose, and audiences. Telephone interviews with 
individuals who were responsible for the development, marketing, and maintenance of these 
websites were conducted strictly for information-gathering purposes. All qualitative and 
statistical data captured during this phase will inform future website enhancements, as well 
as marketing, website optimization, and evaluation activities.
Discussion
The published literature reviewed in the environmental scan indicated that a large body of 
health information is available to patients with cancer on the Internet. Few sites, however, 
offer specific information on infection control among patients with cancer. In addition, the 
gray or unpublished literature reviewed in the environmental scan revealed an abundance of 
cancer-related patient education information on the Internet, but few online patient 
education programs were designed specifically for infection control among patients with 
cancer.
As patients and caregivers frequently look to the Internet to obtain relevant health 
information, an online program may be an effective way to provide patients with 
information to prevent infections. PreventCancerInfections.org can be a valuable addition to 
oncology nurses’ “toolbox” of tools and resources that help educate and empower patients.
In addition to being one of few resources of its kind, another unique benefit of this website 
is that it reflects the insights and recommendations of prominent researchers and healthcare 
providers, the EAB, and intended users (including patients and caregivers). The project team 
used the best available information to create the website and educational messages. Since 
the website’s intended users represented a mixed audience (e.g., patients with cancer, 
caregivers, healthcare providers), the project team was able to ensure the program would 
benefit all audiences by seeking their input at multiple phases of development. In addition, 
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the healthcare providers who participated in the focus groups and the EAB represent 
professional diversity with areas of expertise that were pivotal in evaluating the website for 
essential content, content validity, and usability benefits and challenges.
In addition, many EAB members have indicated a willingness to assist the CDC’s efforts 
with ongoing website refinement, promotion, and evaluation. The ultimate goal is to develop 
methods for sustainability of a user-friendly, credible, trusted, and interactive web-based 
resource designed for patients with cancer undergoing chemotherapy.
One limitation identified in the initial evaluation site visits is that increased use of the 
website may not be feasible for many outpatient facilities given technological challenges 
(computer and Internet access), patient volume, and staff demands. However, increased use 
of the website’s collateral materials is certainly something that can be accomplished. These 
materials exist in the form of fact sheets, brochures, magnets, and other promotional items. 
One way to ensure and increase the use of the PreventCancer Infections.org materials is to 
encourage outpatient facilities to make these resources a consistent, permanent, and 
mandatory part of their patient education and services.
Finally, the developers recognized the importance of ongoing, targeted marketing efforts to 
promote use of the website as well as evaluation activities to better understand patterns of 
use. To help champion the CDC’s targeted marketing efforts, the U.S. Oncology Network, 
one of the nation’s largest networks of community-based oncology physicians, reached out 
to its membership through an email blast, introducing its members to the website and its 
collateral materials. The developers are continuing to identify other similar opportunities for 
partnership in promotion of the website. Also, methods to determine if exposure to this 
information leads to improved outcomes for patients with cancer, including a decrease in 
infections, and an increase in recognizing signs and symptoms by patients and caregivers 
which would lead to earlier diagnosis and treatment, are being explored. If evaluation 
findings warrant, future activities may also include tailoring and refocusing the delivery of 
website materials to adolescent, low literacy, and minority populations.
Conclusion
About 650,000 patients with cancer receive chemotherapy in an outpatient setting annually 
in the United States (Halpern & Yabroff, 2008). Neutropenia is a common and potentially 
dangerous side effect of chemotherapy and results in preventable morbidity and mortality. 
Many patients with cancer and their caregivers may not be aware of this risk and actions 
they can take to minimize their risk of infection. PreventCancer Infections.org is an 
interactive, evidence-based tool for providing information and education to patients with 
cancer undergoing chemotherapy. The goal of the website is to empower patients and their 
caregivers with the knowledge and skills to recognize the signs and symptoms of infection. 
This information should lead patients and caregivers to take actions to seek care for this life-
threatening condition.
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• Educate patients about neutropenia, a common and potentially dangerous side 
effect of chemotherapy that may lead to significant morbidity and mortality.
• Inform patients with cancer and their caregivers about the risk of infection in 
community and healthcare settings and provide them with steps they can take to 
minimize risk.
• Develop an online program as an effective way to provide information on the 
prevention of infections to patients with cancer and their caregivers.
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Questions Included in the Patient Risk Assessment
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Findings From the Two Evaluation Site Visits
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TABLE 1
Focus Group Audiences and Modes
Audience Number of Focus Groups Focus Group Mode
Patients with cancer (age 30 and older) 3 Telephone
Caregivers of patients who are ages 0–17 2 In-person (Atlanta)
Caregivers of patients who are ages 18 and older 2 In-person (Atlanta)
Physicians 2 Online/webinar format
Nurses, including office managers 2 Online/webinar format
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TABLE 2
Selected Elements of Web Metricsa
Metric Data
Number of visits to the site 36,757
Page views 150,241
Pages per visit 2.52
Average visit duration (minutes) 2:00
a
As of July 1, 2014
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